Cell Therapy QC Company, Accellix, Raised $9.5 Million in Series D Round
Jerusalem based, Accellix, the Cell Therapy QC company, had a Series D financing round of $9.5 million led by bioMérieux, a world leader in the field of in vitro diagnostics…
Continue Reading
Cell Therapy QC Company, Accellix, Raised $9.5 Million in Series D Round